Position in ABBV
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$1,736,064
-$18,862 QoQ
Shares Held
6,899
-14.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#881
of 1,985 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $22,172,877 across 17 Drug Manufacturers - General names. ABBV ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,562 | $4,272,370 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
73,361 | $4,227,060 | |
| 3 | JNJ |
Johnson & Johnson
|
13,834 | $3,513,420 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
6,899 | $1,736,064 | |
| 5 | NVS |
Novartis AG
|
10,771 | $1,688,031 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,085 | $1,552,922 | |
| 7 | AZN |
Astrazeneca PLC
|
7,263 | $1,377,210 | |
| 8 | AMGN |
Amgen Inc
|
1,980 | $716,997 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,736,064 | 6,899 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $1,754,926 | 8,069 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,368,198 | 5,988 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,719,416 | 7,426 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $1,008,287 | 5,432 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $1,079,237 | 5,151 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $486,009 | 2,735 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $403,254 | 2,042 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $244,587 | 1,426 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $278,613 | 1,530 | Shares | Sole | 2024-04-03 | |
| 2023-12-31 | $344,963 | 2,226 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $334,341 | 2,243 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $297,753 | 2,210 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $353,642 | 2,219 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $349,400 | 2,162 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $288,819 | 2,152 | Shares | Sole | 2022-12-30 | |
| 2022-06-30 | $322,401 | 2,105 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $340,593 | 2,101 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $283,663 | 2,095 | Shares | Sole | 2022-01-06 | |
| 2021-09-30 | $213,258 | 1,977 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $196,782 | 1,747 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $186,138 | 1,720 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $128,901 | 1,203 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $272,930 | 3,116 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $304,848 | 3,105 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $233,446 | 3,064 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||